http://nanets.net/abstracts-archive/2023-1?format=html Wed, 29 Nov 2023 10:42:03 -0500 en-GB hourly 1 http://nanets.net/abstracts-archive/2023-1/1804-b24-montoni-parp-inhibitors-potentiate-chemotherapy-of-net-cells-and-tumors-and-papr1-knockdown-suppresses-growth-of-net-tumors-in-mice?format=html [B24] Montoni - PARP inhibitors potentiate chemotherapy of NET cells and tumors and PAPR1-knockdown suppresses growth of NET tumors in mice# http://nanets.net/abstracts-archive/2023-1/1804-b24-montoni-parp-inhibitors-potentiate-chemotherapy-of-net-cells-and-tumors-and-papr1-knockdown-suppresses-growth-of-net-tumors-in-mice?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 10:42:03 -0500 http://nanets.net/abstracts-archive/2023-1/1789-b9-daigle-machine-learning-algorithm-to-classify-multiphoton-microscopy-images-of-pancreatic-neuroendocrine-tumors?format=html [B9] Daigle - Machine learning algorithm to classify multiphoton microscopy images of pancreatic neuroendocrine tumors http://nanets.net/abstracts-archive/2023-1/1789-b9-daigle-machine-learning-algorithm-to-classify-multiphoton-microscopy-images-of-pancreatic-neuroendocrine-tumors?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 05:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1790-b10-guenter-notch1-and-notch3-signaling-interplay-regulates-pancreatic-neuroendocrine-cell-proliferation?format=html [B10] Guenter - Notch1 and Notch3 signaling interplay regulates pancreatic neuroendocrine cell proliferation http://nanets.net/abstracts-archive/2023-1/1790-b10-guenter-notch1-and-notch3-signaling-interplay-regulates-pancreatic-neuroendocrine-cell-proliferation?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1791-b11-guenter-the-notch1-pathway-is-a-critical-regulator-of-sstr2-expression-in-neuroendocrine-tumors?format=html [B11] Guenter - The Notch1 pathway is a critical regulator of SSTR2 expression in neuroendocrine tumors http://nanets.net/abstracts-archive/2023-1/1791-b11-guenter-the-notch1-pathway-is-a-critical-regulator-of-sstr2-expression-in-neuroendocrine-tumors?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1792-b12-chen-notch1-receptor-mediated-metabolic-flexibility-promotes-a-survival-advantage-in-pancreatic-neuroendocrine-neoplasms?format=html [B12] Chen - Notch1 receptor-mediated metabolic flexibility promotes a survival advantage in pancreatic neuroendocrine neoplasms http://nanets.net/abstracts-archive/2023-1/1792-b12-chen-notch1-receptor-mediated-metabolic-flexibility-promotes-a-survival-advantage-in-pancreatic-neuroendocrine-neoplasms?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1793-b13-wang-dissecting-the-role-of-neuronal-mimicry-in-pancreatic-neuroendocrine-tumours?format=html [B13] Wang - Dissecting the role of neuronal mimicry in pancreatic neuroendocrine tumours http://nanets.net/abstracts-archive/2023-1/1793-b13-wang-dissecting-the-role-of-neuronal-mimicry-in-pancreatic-neuroendocrine-tumours?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1794-b14-zheng-scandium-43-dotatate-a-novel-positron-emission-tomography-pet-tracer-for-neuroendocrine-tumor-imaging?format=html [B14] Zheng - Scandium-43-DOTATATE, a Novel Positron Emission Tomography (PET) Tracer for Neuroendocrine Tumor Imaging http://nanets.net/abstracts-archive/2023-1/1794-b14-zheng-scandium-43-dotatate-a-novel-positron-emission-tomography-pet-tracer-for-neuroendocrine-tumor-imaging?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1795-b15-tow-investigating-serotonin-metabolism-in-neuroendocrine-cancers?format=html [B15] Tow - Investigating serotonin metabolism in neuroendocrine cancers http://nanets.net/abstracts-archive/2023-1/1795-b15-tow-investigating-serotonin-metabolism-in-neuroendocrine-cancers?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1796-b16-merlin-chemotherapy-mediated-upregulation-of-sstr2-in-net-tumors-in-mice-and-in-tumor-biopsies-from-lung-and-gastroenteropancreatic-net-patients?format=html [B16] Merlin - Chemotherapy-mediated upregulation of SSTR2 in NET tumors in mice and in tumor biopsies from lung- and gastroenteropancreatic-NET patients http://nanets.net/abstracts-archive/2023-1/1796-b16-merlin-chemotherapy-mediated-upregulation-of-sstr2-in-net-tumors-in-mice-and-in-tumor-biopsies-from-lung-and-gastroenteropancreatic-net-patients?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1797-b17-nanayakkara-yap-and-tead-form-a-transcriptional-complex-regulating-neuroendocrine-differentiation-and-tumorigenesis-through-a-modular-mechanism?format=html [B17] Nanayakkara - YAP and TEAD form a transcriptional complex regulating neuroendocrine differentiation and tumorigenesis through a modular mechanism http://nanets.net/abstracts-archive/2023-1/1797-b17-nanayakkara-yap-and-tead-form-a-transcriptional-complex-regulating-neuroendocrine-differentiation-and-tumorigenesis-through-a-modular-mechanism?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1798-b18-watkins-identifying-the-relationship-between-neuroendocrine-tumors-net-and-glutamic-acid-decarboxylase-65-gad65-antibody?format=html [B18] Watkins - Identifying the relationship between neuroendocrine tumors (NET) and glutamic acid decarboxylase 65 (GAD65) antibody.

 

]]> http://nanets.net/abstracts-archive/2023-1/1798-b18-watkins-identifying-the-relationship-between-neuroendocrine-tumors-net-and-glutamic-acid-decarboxylase-65-gad65-antibody?format=html

 

]]> wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1799-b19-knapp-label-free-phenotyping-of-duodenal-neuroendocrine-tumors-using-tissue-autofluorescence-microscopy-and-digital-spatial-profiling?format=html [B19] Knapp - Label-free phenotyping of duodenal neuroendocrine tumors using tissue autofluorescence microscopy and digital spatial profiling http://nanets.net/abstracts-archive/2023-1/1799-b19-knapp-label-free-phenotyping-of-duodenal-neuroendocrine-tumors-using-tissue-autofluorescence-microscopy-and-digital-spatial-profiling?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1800-b20-kulathunga-establishment-of-novel-pdxovo-models-for-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens?format=html [B20] Kulathunga - Establishment of novel PDXovo models for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) http://nanets.net/abstracts-archive/2023-1/1800-b20-kulathunga-establishment-of-novel-pdxovo-models-for-gastroenteropancreatic-neuroendocrine-neoplasms-gep-nens?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1801-b21-sukrithan-transcriptomic-profiling-of-the-bcl-2-pathway-in-neuroendocrine-neoplasms-nens?format=html [B21] Sukrithan - Transcriptomic profiling of the BCL-2 pathway in Neuroendocrine Neoplasms (NENs) http://nanets.net/abstracts-archive/2023-1/1801-b21-sukrithan-transcriptomic-profiling-of-the-bcl-2-pathway-in-neuroendocrine-neoplasms-nens?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1802-b22-sukrithan-germline-whole-exome-sequencing-of-patients-with-neuroendocrine-neoplasms-nens-reveals-pathogenic-or-likely-pathogenic-variants-in-a-large-subset-of-patients?format=html [B22[ Sukrithan - Germline whole-exome sequencing of patients with neuroendocrine neoplasms (NENs) reveals pathogenic or likely pathogenic variants in a large subset of patients http://nanets.net/abstracts-archive/2023-1/1802-b22-sukrithan-germline-whole-exome-sequencing-of-patients-with-neuroendocrine-neoplasms-nens-reveals-pathogenic-or-likely-pathogenic-variants-in-a-large-subset-of-patients?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1803-b23-herring-calreticulin-is-associated-with-clinical-characteristics-in-pancreatic-neuroendocrine-tumors?format=html [B23] Herring - Calreticulin is Associated with Clinical Characteristics in Pancreatic Neuroendocrine Tumors http://nanets.net/abstracts-archive/2023-1/1803-b23-herring-calreticulin-is-associated-with-clinical-characteristics-in-pancreatic-neuroendocrine-tumors?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1805-b25-eagal-a-sting-operation-in-neuroendocrine-neoplasms?format=html [B25] Eagal - A STING Operation in neuroendocrine neoplasms http://nanets.net/abstracts-archive/2023-1/1805-b25-eagal-a-sting-operation-in-neuroendocrine-neoplasms?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1806-b26-seo-cancer-testis-antigen-and-interleukin-expression-correlates-with-survival-in-small-bowel-neuroendocrine-tumors?format=html [B26] Seo - Cancer testis antigen and interleukin expression correlates with survival in small bowel neuroendocrine tumors http://nanets.net/abstracts-archive/2023-1/1806-b26-seo-cancer-testis-antigen-and-interleukin-expression-correlates-with-survival-in-small-bowel-neuroendocrine-tumors?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1807-b27-forsythe-development-of-gep-nen-patient-derived-organoids-for-therapy-screening?format=html [B27] Forsythe - Development of GEP-NEN Patient Derived Organoids for Therapy Screening http://nanets.net/abstracts-archive/2023-1/1807-b27-forsythe-development-of-gep-nen-patient-derived-organoids-for-therapy-screening?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500 http://nanets.net/abstracts-archive/2023-1/1808-b28-kaemmer-therapies-targeting-cdk4-6-cause-regression-immune-cell-activation-and-sensitization-to-pd-l1-immunotherapy-in-pancreatic-neuroendocrine-tumors?format=html [B28] Kaemmer - Therapies targeting CDK4/6 cause regression, immune cell activation, and sensitization to PD-L1 immunotherapy in pancreatic neuroendocrine tumors http://nanets.net/abstracts-archive/2023-1/1808-b28-kaemmer-therapies-targeting-cdk4-6-cause-regression-immune-cell-activation-and-sensitization-to-pd-l1-immunotherapy-in-pancreatic-neuroendocrine-tumors?format=html wertherm@adgcommunications.com (Maureen Werther) 2023 Wed, 29 Nov 2023 00:00:00 -0500